Lindsay N. Carpp

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa — South Africa

Immunology and Microbiology · Life Sciences

30h-index5.0kcitations103works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(34), SARS-CoV-2 and COVID-19 Research(32), COVID-19 Clinical Research Studies(17), vaccines and immunoinformatics approaches(17), HIV/AIDS drug development and treatment(15)

Publications103 total

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
UNC Libraries·2025Open Access
Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine
Clinical Infectious Diseases·2025Open Access
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
Nature Communications·2025· 1 citedOpen Access
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial
iScience·2025Open Access
Bayesian estimation of HIV acquisition dates for prevention trials
mBio·2025· 2 citedOpen Access
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320
EBioMedicine·2025Open Access
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Emerging Microbes & Infections·2025· 1 citedOpen Access
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2025Open Access
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Nature Communications·2024· 15 citedOpen Access
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
UNC Libraries·2024Open Access
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
UNC Libraries·2024Open Access
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial
Nature Communications·2024· 7 citedOpen Access
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
EBioMedicine·2024· 13 citedOpen Access
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses
Viruses·2024· 2 citedOpen Access
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Nature Communications·2024Open Access
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
Nature Communications·2024· 9 citedOpen Access
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features
Proceedings of the National Academy of Sciences·2024· 18 citedOpen Access
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Nature Communications·2023· 18 citedOpen Access
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
UNC Libraries·2023Open Access
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
UNC Libraries·2023Open Access
page 1 of 6Next →

Frequent Co-authors

Peter B. Gilbert(33), Lawrence Corey(23), Youyi Fong(17), David Benkeser(14), James G. Kublin(13), Yunda Huang(13), Michal Juraska(13), David C. Montefiori(11), Kathleen M. Neuzil(11), Dean Follmann(11), Ying Huang(11), Holly Janes(11), Georgia D. Tomaras(11), Richard A. Koup(10), Chenchen Yu(9), Bhavesh Borate(9), Shelly Karuna(9), M. Juliana McElrath(9), Christopher R. Houchens(8), Karen Martins(8)